Effect of Extubation on Respiratory Function
PULMOVISTA
Electrical Impedance Tomography: Effect of Extubation on Functional Residual Capacity
2 other identifiers
interventional
34
1 country
1
Brief Summary
The extubation phase is a risky period of anesthesia management. During this step, serious complications can arise: hypoxemia, laryngospasm, pharyngeal obstruction, pneumonia… In spite of these complications, extubation and its impact on respiratory function, particularly on the Functional Residual Capacity (FRC), remains poorly studied because of the difficulty to make bedside measurements. The PulmoVista 500 is a clinical routine which provide effective non-invasive bedside measurements. It would be interesting to evaluate the impact of extubation on respiratory function, and more specifically FRC changes during and after extubation. This study will allow a better physiopathological knowledge and a quality improvement patient extubation management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 1, 2021
CompletedFirst Posted
Study publicly available on registry
October 14, 2021
CompletedStudy Start
First participant enrolled
November 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedApril 13, 2026
April 1, 2026
8 months
October 1, 2021
April 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
End Expiratory Lung Impedance (EELI)
EELI variation before and at different timepoints after extubation: T0, T5, T10, T15 and T20 (min).
Between 2 and 3 hours
Secondary Outcomes (4)
Tidal volume distribution
Between 2 and 3 hours
Tidal volume distribution depending on patient position
Between 2 and 3 hours
Tidal volume distribution depending on surgery type and duration
Between 2 and 3 hours
Tidal volume distribution depending on ventilatory mode
Between 2 and 3 hours
Study Arms (1)
Functional residual capacity
EXPERIMENTALFunctional residual capacity measure during and after extubation
Interventions
Patient functional residual capacity will be measured by electrical impedance tomography before extubation and then at 0, 10, 15 and 20 min after extubation.
Eligibility Criteria
You may qualify if:
- Patient over 18 years
- Patient in operating room for scheduled surgery
- Patient receiving general anaesthesia with orotracheal intubation
- Patient given written consent after information
- Patient covered by social security or equivalent regimen
You may not qualify if:
- Patient undergoing thoracic and spinal surgery, due to the presence of dressings that interfere with measurements,
- Patient who has undergone intracerebral surgery because of possible communication difficulties upon awakening,
- Patients with a body mass index (BMI) \> 50 (measurements not possible)
- Pregnant or breastfeeding patient,
- Patient contraindicated to the use of a thoracic electroimpedancemetry technique: dressings, wounds, presence of a pacemaker, defibrillator or any other active implant.
- Patient deprived of liberty by a judicial or administrative decision or patient subject to a legal protection measure (guardianship, curatorship...)
- Any other reason that, in the opinion of the investigator, could interfere with the evaluation of study objectives
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital d'Instruction des Armées de Sainte Anne
Toulon, Var, 83100, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Clarisse LEGER, Nurse
Hôpital d'instruction des armées Sainte-Anne
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 1, 2021
First Posted
October 14, 2021
Study Start
November 5, 2021
Primary Completion
June 30, 2022
Study Completion
June 30, 2022
Last Updated
April 13, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share